TLDR
- ARK Invest purchased $4 million in Intellia Therapeutics and over $300 million in BitMine crypto infrastructure stock
- Wood sold $5.35 million in Roku shares and $2.61 million in DraftKings positions across multiple ETFs
- BitMine has gained 534.9% year-to-date while Intellia surged 56% over three months
- Portfolio rebalancing shows shift from streaming and gaming toward biotech and cryptocurrency sectors
- ARK’s total BitMine investment now exceeds $300 million across three flagship funds
Cathie Wood’s ARK Invest executed major trades this week, making substantial investments in cryptocurrency infrastructure and gene-editing biotechnology. The celebrity investor’s flagship funds purchased millions in high-growth stocks while trimming positions in entertainment companies.
ARK’s biggest move involved BitMine Immersion Technologies, buying 15.6 million shares worth over $300 million. The purchase spanned three ETFs: ARK Innovation (227,569 shares), ARK Next Generation Internet (70,991 shares), and ARK Fintech Innovation (40,553 shares).
BitMine operates Ethereum treasury management and crypto mining operations. The company holds 1.71 million ETH tokens valued at approximately $7.9 billion. BitMine stock has skyrocketed 534.9% year-to-date despite recent volatility.
Gene-Editing Investment Signals Healthcare Focus
Wood’s funds also purchased 349,930 Intellia Therapeutics shares worth $4 million. Intellia develops CRISPR gene-editing treatments for genetic diseases including transthyretin amyloidosis and hereditary angioedema.
The biotech stock has gained 56% over three months as ARK consistently added shares. Wood has compared gene-editing potential to the internet’s transformative impact on communication.
Intellia represents ARK’s continued healthcare innovation focus. The company’s pipeline targets rare genetic disorders with limited treatment options.
Roku and DraftKings Positions Trimmed
ARK simultaneously reduced entertainment holdings, selling 55,624 Roku shares for $5.35 million. The streaming device maker has gained 31.2% year-to-date but faced consistent ARK selling pressure.
DraftKings also saw reductions with 54,679 shares sold across three funds for $2.61 million. The sports betting company has returned 29.7% this year despite regulatory headwinds.
These sales appear tactical, redirecting capital toward higher-conviction plays in biotech and crypto infrastructure.
Market Impact and Future Outlook
Wood’s trades influenced after-hours trading with BitMine and Intellia gaining momentum. Her $50 billion asset management empire often drives retail investor interest in targeted stocks.
The rebalancing reflects Wood’s bullish Ethereum thesis. She projects the cryptocurrency could reach $166,000 by 2032, representing massive upside from current $4,635 levels.
ARK’s strategy focuses on disruptive technologies across genomics, artificial intelligence, and blockchain infrastructure. Recent trades reinforce this long-term vision.
BitMine’s Ethereum treasury positions the company for potential cryptocurrency appreciation. Intellia’s gene-editing platform could revolutionize treatment for genetic diseases.
Wood continues betting on transformative technologies despite market volatility. Her latest moves signal confidence in crypto infrastructure and precision medicine sectors.
